Complement component C7 deficiency in a Spanish family

Clinical and Experimental Immunology

Volumn 133, Issue 2, 2003, Pages 240-246

  Vazquez Bermudez M F ^a   Barroso, S ^a   Walter, K ^a   Alvarez A J ^a   Alarcon A ^a   Lopez Trascasa M ^b   Wichmann, I ^a   Aguilar, F ^a   Nunez Roldan A ^a   Sánchez, Berta ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^b HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

C7 deficiency; Fc ; Meningococcal infections; Moroccan sephardic Jews; Receptors

Indexed keywords

COMPLEMENT COMPONENT C7; FC RECEPTOR; OPSONIN;

ALLOTYPE; AMINO ACID SUBSTITUTION; ARTICLE; CASE REPORT; COMPLEMENT DEFICIENCY; ETHNOLOGY; EXON; FAMILY; FEMALE; GENE MUTATION; GENETIC POLYMORPHISM; HETEROZYGOSITY; HUMAN; INFECTION SENSITIVITY; MALE; MENINGOCOCCOSIS; MISSENSE MUTATION; MUTATIONAL ANALYSIS; PATHOGENESIS; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECURRENT INFECTION; STOP CODON;

BASE SEQUENCE; COMPLEMENT C7; DISEASE SUSCEPTIBILITY; FEMALE; HUMANS; MALE; MENINGOCOCCAL INFECTIONS; MOLECULAR SEQUENCE DATA; MUTATION; OPPORTUNISTIC INFECTIONS; PEDIGREE; RECEPTORS, IGG;

EID: 0043033215     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2003.02186.x     Document Type: Article

References (39)

1. Sullivan KE, Winkelstein JA. Genetically determined deficiencies of the complement system. In: Ochs HD, Smith CIE, Puck JM, eds. Primary Immunodeficiency Diseases. A Molecular and Genetic Approach. New York: Oxford University Press, 1999:397-418.
2. Figueroa JE, Densen P. Infectious disease associated with complement deficiencies. Clin Microb Rev 1991; 4:359-95.
3. Goldschneider I, Gotslich EC, Artenstein MS. Human immunity to the meningococcus. I. The role of humoral antibodies. J Exp Med 1969; 129:1307-48.
4. Müller-Eberhard HJ. The membrane attack complex of complement. Annu Rev Immunol 1986; 4:503-28.
5. DiScipio RG, Chakravarti DN, Muller-Eberhard HJ, Fey GH. The structure of human complement component C7 and the C5b-7 complex. J Biol Chem 1988; 263:549-60.
6. Hobart MJ, Fernie BA, DiScipio RG. Structure of the human C7 gene and comparison with the C6, C8A, C8B, and C9 genes. J Immunol 1995; 154:5188-94.
7. Abbott C, West L, Povey S, Jeremiah S, Murad Z, DiScipio RG, Fey G. The gene for the human complement component C9 mapped to chromosome 5 by polymerase chain reaction. Genomics 1989; 4:605-9.
8. Fernie BA, Orren A, Sheehan G, Schlesinger M, Hobart MJ. Molecular basis of C7 deficiency. Three different defects. J Immunol 1997; 159:1019-26.
9. Salmon JE, Edberg JC, Brogle NL, Kimberly RP. Allelic polymorphism of human FcγReceptor IIA and FcγReceptor IIIB. Independent mechanisms for differences in human phagocyte function. J Clin Invest 1992; 89:1274-81.
10. Fijen CAP, Bredius RGM, Kuijper EJ, Out TA, de Haas M, de Wit APM. The role of Fcγ receptor polymorphisms and C3 in the immune defence against Neisseria meningitidis in complement-deficient individuals. Clin Exp Immunol 2000; 120:338-45.
11. Deo YM, Graziano RF, Repp R, van de Winkel JG. Clinical significance of IgG Fc receptors and Fc gamma R-directed immunotherapies. Immunol Today 1997; 18:127-35.
12. van Wamerdam PA, van de Winkel JG, Vlug A, Westerdaal NA, Capel PJ. A single amino acid in the second Ig-like domain of the human Fcγ receptor II is critical for human IgG2 binding. J Immunol 1991; 147:1338-43.
13. van de Winkel JGJ, Capel PJA. Human IgG Fc receptor heterogeneity. molecular and clinical implications. Immunol Today 1993; 14:215-21.
14. Bredius RGM, Derkx BHF, Fijen CAP, de Wit TP, de Haas M, Weening RS, van de Winkel JG, Out TA. Fcγreceptor IIa (CD32) polymorphism in fulminant meningococcal septic shock in children. J Infect Dis 1994; 170:848-53.
15. Segurado OG, Arnáiz-Villena A, Iglesias-Casarrubios P, Martínez-Laso J, Vicario JL, Fontán G, López-Trascasa M. Combined total deficiency of C7 and C4B with systemic lupus erythematosus (SLE). Clin Exp Immunol 1992; 87:410-4.
16. Kawasaki E. Sample preparation from blood, cells and other fluids. In: Innis M, Gelfand D, Sinisky J, White T, eds. PCR Protocols. A Guide to Methods and Applications. San Diego: Academic Press, 1990:146-52.
17. Nishizaka H, Horiuchi T, Zhu ZB, Fukumori Y, Volanakis JE. Genetic bases of human complement C7 deficiency. J Immunol 1996; 157:4239-43.
18. Devereux J, Haeberli P, Smithies O. A comprehensive set of sequence analysis for the VAX. Nucl Acid Res 1984; 12:387-95.
19. Flesch BK, Bauer F, Neppert J. Rapid typing of the human Fc gamma receptor IIA polymorphism by polymerase chain reaction amplification with allele-specific primers. Transfusion 1998; 38:174-6.
20. Hessner MJ, Curtis BR, Endean DJ, Aster RH. Determination of neutrophil antigen gene frequencies in five ethnic groups by polymerase chain reaction with sequence-specific primers. Transfusion 1996; 36:895-9.
21. Fernie BA, Würzner R, Unsworth DJ, Tuxworth RI, Hobart MJ. Molecular basis of the complement C6 and C7 genes. Ann Hum Genet 1995; 59:163-81.
22. Würzner R, Fernie BA, Jones AM, Lachmann Pj, Hobart MJ. Molecular basis of the complement MN polymorphism-a neutral amino acid substitution outside the epitope of the allospecific monoclonal antibody. J Immunol 1995; 154:4813-9.
23. Fernie BA, Orren A, Schlesinger M, Würzner R, Platonov AE, Cooper RC, Williams YE, Hobart MJ. DNA haplotypes of the complement C6 and C7 genes associated with deficiencies of the seventh component; and a new polymorphism in C7 exon 13. Ann Hum Genet 1997; 61:287-98.
24. Fernie BA, Hobart MJ. Complement C7 deficiency, seven further molecular defects and their associated marker hapolotypes. Hum Genet 1998; 103:513-9.
25. O'Hara AM, Fernie BA, Moran AP, Williams YE, Connaughton JJ, Orren A, Hobart MJ. C7 deficiency in an Irish family: a deletion defect which is predominant in the Irish. Clin Exp Immunol 1998; 114:355-61.
26. Würzner R, Witzel-Schlömp K, Tokunaga K, Fernie BA, Hobart MJ, Orren A. Reference typing report for complement components C6, C7 and C9 including mutations leading to deficiencies. Exp Clin Immunogenet 1998; 15:268-85.
27. Horiuchi T, Ferrer JM, Serra P, Matamoros N, López-Trascasa M, Hashimura C, Niho Y. A novel nonsense mutation at Glu-631 in a Spanish family with complement component 7 deficiency. J Human Genet 1999; 44:215-8.
28. Fernie BA, Würzner R, Orren A et al. Molecular bases of combined and subtotal deficiencies of C6 and C7 and their effects in combination with other C6 and C7 deficiencies. J Immunol 1996; 157:3648-57.
29. Doolittle RF. The multiplicity of domains in proteins. Annu Rev Biochem 1995; 64:287-314.
30. Hobart M. C7. In Morley BJ, Walport MJ, eds. The Complement Facts Book. London: Academic Press, 2000:117-22.
31. Würzner R, Hobart MJ, Fernie BA, Mewar D, Potter PC. Molecular basis of subtotal complement C6 deficiency. J Clin Invest 1995; 95:1877-83.
32. Platonov AE, Würzner R, Belobodorov B, Jones AM, Trshansky DV, Vershinina IV, Lachmann PJ, Orren A. Paradoxical reconstitution of complement activity following plasma transfusion of an individual with deficiency of the seventh component of complement. Immunology 1994; 81:142-8.
33. Würzner R, Platonov AE, Belobodorov VB, Pereverzeb AI, Vershinina IV, Fernie BA, Hobart MJ, Lachmann PJ, Orren A. How partial C7 deficiency with chronic and recurrent bacterial infections can mimic total C7 deficiency: temporary restoration of Host C7 levels following plasma transfusion. Immunology 1996; 88:407-11.
34. Crespí C, Milá J, Martínez-Pomar N et al. HLA polymorphism in a Majorcan population of Jewish descent: Comparison with Majorca, Minorca, Ibiza (Balearic Islands) and other Jewish communities. Tissue Antigens 2002; 60:282-91.
35. Halle D, Elstein D, Geudalia D, Sasson A, Shinar E, Schlesinger M, Zinram A. High prevalence of complement C7 deficiency among healthy blood donors of Moroccan Jewish ancestry. Am J Med Genet 2001; 99:325-7.
36. Platonov AE, Shipulin GA, Vershinina IV, Dankert J, van de Winkel JGJ, Kuijper EJ. Association of human FcγRIIa (CD32) polymorphism with susceptibility to and severity of meningococcal disease. Clin Infect Dis 1998; 27:746-50.
37. Platonov AE, Kuijper EJ, Vershinina IV, Shipulin GA, Westerdaal N, Fijen CAP, van de Winkel JGJ. Meningococcal disease and polymorphism of FcγRIIa (CD32) in late complement component-deficient individuals. Clin Exp Immunol 1998; 111:97-101.
38. van der Pol WL, Huizinga TWJ, Vidarsson G et al. Relevance of Fcγ receptor and interleukin-10 polymorphism for meningococcal disease. J Infect Dis 2001; 184:1548-55.
39. Tsokos GC, Liossis SNC. Immune cell signaling defects in lupus, activation, anergy and death. Immunol Today 1999; 20:119-24.